Efficacy and Safety of Low-dose Rituximab in the Treatment of Refractory Myasthenia Gravis
Clinical trial NCT05332587 · UNKNOWN
Trial details
- NCT number
- NCT05332587
- Sponsor
- First Affiliated Hospital, Sun Yat-Sen University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-01
- Primary completion
- 2022-07-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.